Skip to main content
Clinical Trials/NCT04062500
NCT04062500
Recruiting
Not Applicable

Registry for Longitudinal Mortality and Therapy in Patients With Heart Failure (GREARTWAL Study)

Shanghai 10th People's Hospital1 site in 1 country10,500 target enrollmentJanuary 1, 2018
ConditionsHeart Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Heart Failure
Sponsor
Shanghai 10th People's Hospital
Enrollment
10500
Locations
1
Primary Endpoint
Mortality of acute decompensated heart failure
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this registry is to compile a large clinical database on the medical management of patients hospitalized with acute heart failure, using information collected from hospitals across China.

Detailed Description

Registry for Longitudinal mortality and therapy in patients with Heart Failure is a large, multicenter, prospective, open-label registry of the management of patients treated in the hospital for acute heart failure in China. The objective of this study is to investigate the clinical features and prognosis of patients with heart failure, and discover the characteristics of high-risk heart failure patients, and elucidate critical factors which predict the development and outcomes of symptomatic heart failure patients. 1. To elucidate the clinical characteristics and prognostic risks of patients with heart failure. 2. To study the characteristics of high-risk heart failure patients and predict the key factors for the development of symptomatic heart failure patients. 3. To elucidate the compliance of patients with heart failure and the incidence of adverse drug effects. 4. To investigate the effect of self-management on outcomes in patients with heart failure. 5. To elucidate critical factors associated with the development and outcomes of heart failure. 6. To investigate hospitalization expenses for heart failure.

Registry
clinicaltrials.gov
Start Date
January 1, 2018
End Date
December 31, 2027
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Shanghai 10th People's Hospital
Responsible Party
Principal Investigator
Principal Investigator

Ya-Wei Xu

MD, pHD, Director of Cardiovascular Department

Shanghai 10th People's Hospital

Eligibility Criteria

Inclusion Criteria

  • 18 years and older.
  • Meet the diagnostic criteria of China 2018 or JACC/AHA 2017 or ESC 2016 heart failure guidelines.
  • Agree to be tested and sign an informed consent certificate.

Exclusion Criteria

  • Age\<18 years old.
  • Patients who refused to participate.
  • Patients may have a life expectancy of less than 1 years due to non- heart failure clinical conditions.

Outcomes

Primary Outcomes

Mortality of acute decompensated heart failure

Time Frame: 10 years

In-hospital and Annual mortality

Re-hospitalization rate

Time Frame: 10 years

Re-hospitalization of acute decompensated heart failure

Study Sites (1)

Loading locations...

Similar Trials